Risk Partners Life Sciences Roundtable 2025, thank you very much! 

Contact us

We congratulate Steyr Motors AG on the successful listing
in the Scale Segment of the German Stock Exchange on October 30, 2024!

Risk Partners had the honor to act as IPO underwriting counsel in this transaction. Our team, led by Florian Eckstein and Björn Stressenreuter, supported Steyr Motors AG in its IPO on the Frankfurt Stock Exchange. Our expertise and comprehensive support were geared towards providing Steyr Motors with a secure and successful start on the capital markets.

We would like to thank Julian Cassutti and Christoph Cerar from Steyr Motors and the team at Mutares SE & Co. KGaA for the successful cooperation and their trust in our expertise.

With this step, Steyr Motors AG has not only gained access to additional capital for further growth, but has also strengthened its position as an innovation leader in the field of engine technology. 

About the Scale Segment of Deutsche Börse

Deutsche Börse's Scale segment offers small and medium-sized companies more straightforward access to the capital market and facilitates the financing of innovation and growth projects. Companies in the Scale segment benefit from a standardized listing process and special advisory networks that help them to master the challenges of the capital market with confidence.

At Risk Partners, we pride ourselves on supporting companies like Steyr Motors AG with specialized insurance solutions and comprehensive advice. From management liability insurance to innovative insurance products specifically tailored to the challenges and opportunities of an IPO, we offer customized solutions for our clients. When going public on a German stock exchange or through our innovative public flip concept when going public on a foreign stock exchange.

Ready for the next step?

For companies that are also looking to go public, Risk Partners offers tailor-made insurance solutions and advice to make this step a safe one. Contact us to find out how we can support you on your journey to the stock market.

Also read our other blog posts
Management

Research breakdown at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research

Research mishap at Stockholm's Karolinska Institute: A cooling failure destroys cell cultures from decades of research - can you insure against it? An incident that threatens your very existence, but which we would like to shed some light on from the perspective of an insurance broker specializing in life sciences. What happened? A cooling system at the Karolinska Institute in Stockholm, Sweden's most important medical research center, failed for five days. Biological material that had been collected over 30 years and, according to the institute, was unique in the world, was destroyed as a result. The material was stored in deep-freeze tanks in which the temperature

Read more "
June 7, 2024
Being Public

Public prosecutor's office investigates: Suspicion of deception in short-time work (Sono Motors)

No startup bonus for criminal and administrative offenses. The incident and possible insurance cover. As exclusively researched by Hannah Schwär and her team at Capital Magazin, the founders of Sono Motors are now also facing problems with the public prosecutor's office. According to Capital Magazin, subsidy fraud in the context of short-time work and the programs surrounding the corona crisis is in the offing. The company, which is listed on the NASDAQ via De-SPAC, has already filed a report with the SEC. While the loss amount of EUR 40,000 is still being

Read more "
March 19, 2024
Being Public

Digital and effective prevention of directors' and officers' liability by Risk Partners & Fides Technology

Innovation by Risk Partners & Fides Technology Now on Vimeo and Soundcloud: get practical tips from experts with high relevance for avoiding liability for business managers. Question unanswered? Content: Personal liability is a constant sword of Damocles hovering over managing directors in everyday life. The standard of care is strict and directors bear the burden of proof. In collaboration with the distinguished corporate lawyer Eva Homborg (Esche Schümann Commichau) and the governance expert Philippa Peters (Fides Technology GmbH), we have spent months compiling practical measures on how you can avoid this burden of proof.

Read more "
January 12, 2024
Cyber Security

"Digital Operational Resilience Act" (DORA regulation) from the perspective of venture capital and private equity funds

DORA regulation applies from January 2025. Significance for our private equity and venture capital clients The somewhat unwieldy name "Digital Operational Resilience Act" (DORA for short) has a very serious background and is fundamentally to be welcomed. After all, when we evaluate our claims in the context of cybercrime, PE and VC funds and their KVGs are those with the highest frequency of claims. It can be safely assumed that they are a "worthwhile target group" for cyber criminals based abroad.

Read more "
December 27, 2024
IPO

New: Risk Partners POSI Insurance for MiCAR White Paper

MiCAR Compliance? We Cover the Risk! The MiCAR Regulation (EU 2023/1114) exposes crypto-asset service providers and whitepaper authors to significant liability risks. Incomplete, inaccurate, or misleading information in white papers can have significant consequences for Crypto-Asset Service Providers (CASP) and authors—ranging from regulatory sanctions to civil claims. Our solution: Risk Partners Tech POSI MiCAR Whitepaper Protect 2025 The creation and publication of white papers under MiCAR entails complex liability pitfalls: In addition to civil claims (e.g., under the German Civil Code) and criminal risks, there is a threat of

Read more "
March 21, 2026
Life Sciences

Atrialis GmbH - experts in clinical trial insurance

Atrialis GmbH - experts in clinical trial insurance & Risk Partners will play in the same team in the future. LifeSciences - Leading risk concepts for leading science! Under this guiding principle, we have been able to advise innovative companies from the biotechnology, pharmaceutical and medical device sectors comprehensively on risk issues for many years and support them with suitable insurance solutions in all growth and study phases, from foundation to IPO and beyond (e.g. insuring a clinical trial). Together with my team at Risk Partners GmbH, we would like to continue our focus, our passion

Read more "
October 31, 2023